These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 3515558)

  • 1. Hemorrhagic complications of anticoagulant therapy.
    Levine MN; Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):39-57. PubMed ID: 3515558
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of anticoagulants.
    Hirsh J
    Semin Thromb Hemost; 1986 Jan; 12(1):21-37. PubMed ID: 3515557
    [No Abstract]   [Full Text] [Related]  

  • 3. Risks and benefits of anticoagulant therapy.
    Levine MN
    Semin Thromb Hemost; 1986 Jan; 12(1):67-71. PubMed ID: 3961508
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemorrhagic complications of long-term anticoagulant therapy.
    Levine MN; Raskob G; Hirsh J
    Chest; 1986 Feb; 89(2 Suppl):16S-25S. PubMed ID: 3510826
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulation in aged patients with chronic non-rheumatic atrial fibrillation].
    Rodríguez D; Agustí A
    Med Clin (Barc); 1999 Mar; 112(11):436-7. PubMed ID: 10231778
    [No Abstract]   [Full Text] [Related]  

  • 6. Anticoagulant treatment of venous thromboembolism.
    Coon WW
    Surg Annu; 1972; 4():151-63. PubMed ID: 4668856
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
    Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bleeding complications in oral anticoagulant treatment].
    Gulløv AL; Koefoed BG; Petersen P
    Nord Med; 1995; 110(4):114-8. PubMed ID: 7724354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview.
    Bernardi E; Piccioli A; Oliboni G; Zuin R; Girolami A; Prandoni P
    Thromb Haemost; 2000 Jul; 84(1):22-6. PubMed ID: 10928464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drugs in the treatment of thrombo-embolic disease--part I.
    Bouchier-Hayes D
    Ir Med J; 1983 Feb; 76(2):101-5, 107. PubMed ID: 6601642
    [No Abstract]   [Full Text] [Related]  

  • 11. Activated partial thromboplastin time monitoring in patients receiving unfractionated heparin for venous thromboembolism in relation to clinical outcomes.
    Vardi M; Laor A; Bitterman H
    Thromb Haemost; 2009 Nov; 102(5):879-86. PubMed ID: 19888523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 13. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
    Frantz E
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
    [No Abstract]   [Full Text] [Related]  

  • 14. [Anticoagulation in stroke. Evidence-based and empirical indications].
    Walter U; Kloth A; Benecke R; Kunesch E
    Dtsch Med Wochenschr; 2003 Oct; 128(42):2200-5. PubMed ID: 14562219
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anticoagulation in pregnancy and post partum in heat valve diseases, thrombosis or atrial fibrillation: fetal risk versus maternal thromboembolism].
    Gohlke-Bärwolf C
    Z Kardiol; 2001; 90 Suppl 4():49-56. PubMed ID: 11373944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulants: the state of the art.
    Gallus AS
    Aust Fam Physician; 1982 Jan; 11(1):14-22. PubMed ID: 7065989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unfractionated heparin therapy in infants and children.
    Newall F; Johnston L; Ignjatovic V; Monagle P
    Pediatrics; 2009 Mar; 123(3):e510-8. PubMed ID: 19221154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients.
    Torn M; Cannegieter SC; Bollen WL; van der Meer FJ; van der Wall EE; Rosendaal FR
    Arch Intern Med; 2009 Jul; 169(13):1203-9. PubMed ID: 19597069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.